Apyx Medical
APYX
78 hedge funds and large institutions have $97.2M invested in Apyx Medical in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 9 closing their positions.
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
78% more call options, than puts
Call options by funds: $132K | Put options by funds: $74K
45.22% more ownership
Funds ownership: 0% → 45.22% (+45%)
28% more funds holding
Funds holding: 61 → 78 (+17)
11% more capital invested
Capital invested by funds: $87.7M → $97.2M (+$9.51M)
27% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 26
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$5.67M |
| 2 |
Millennium Management
New York
|
+$3.72M |
| 3 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
+$1.76M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.65M |
| 5 |
QI
QS Investors
New York
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$3.5M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.7M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.02M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$962K |
| 5 |
Barclays
London,
United Kingdom
|
-$954K |
APYX Hedge Fund Activity: Q1 2019 in Review
78 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2019, worth a combined $97.2M — up 11% from $87.7M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new APYX positions and 9 closed out — a net gain of 18 holders — while 19 added to existing stakes and 26 trimmed.
The largest buyer was RTW Investments, adding an estimated $5.67M. The largest seller was Archon Capital Management, cutting an estimated $3.5M.
- 78 institutional investors held Apyx Medical (APYX) as of Q1 2019, up from 61 in Q4 2018.
- Funds reported $97.2M of Apyx Medical stock for Q1 2019, up 11% quarter-over-quarter.
- 27 funds opened new Apyx Medical positions in Q1 2019 and 9 closed out, a net change of +18 holders.
- The largest Apyx Medical buyer in Q1 2019 was RTW Investments, an estimated $5.67M added.
- The largest Apyx Medical seller in Q1 2019 was Archon Capital Management, an estimated $3.5M sold.
Based on aggregated 13F filings for Q1 2019.